Success Metrics

Clinical Success Rate
77.8%

Based on 7 completed trials

Completion Rate
78%(7/9)
Active Trials
1(9%)
Results Posted
86%(6 trials)
Terminated
2(18%)

Phase Distribution

Ph phase_2
3
27%
Ph phase_4
1
9%
Ph phase_1
2
18%
Ph phase_3
5
45%

Phase Distribution

2

Early Stage

3

Mid Stage

6

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
2(18.2%)
Phase 2Efficacy & side effects
3(27.3%)
Phase 3Large-scale testing
5(45.5%)
Phase 4Post-market surveillance
1(9.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

70.0%

7 of 10 finished

Non-Completion Rate

30.0%

3 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(7)
Terminated(3)

Detailed Status

Completed7
Terminated2
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
77.8%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (18.2%)
Phase 23 (27.3%)
Phase 35 (45.5%)
Phase 41 (9.1%)

Trials by Status

recruiting19%
terminated218%
completed764%
withdrawn19%

Recent Activity

1 active trials
Showing 5 of 11
recruitingphase_2

A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza

NCT05648448
completedphase_3

Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza

NCT02369159
completedphase_3

Safety, PK and Effectiveness of IV Peramivir in Elderly and Higher Risk Subjects With Uncomplicated Influenza

NCT02635724
terminatedphase_3

Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza

NCT00610935
completedphase_4

ED Influenza Therapeutic Pilot Study: Oseltamivir vs. Peramivir

NCT02609399
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT05648448Phase 2

A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza

Recruiting
NCT02369159Phase 3

Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza

Completed
NCT02635724Phase 3

Safety, PK and Effectiveness of IV Peramivir in Elderly and Higher Risk Subjects With Uncomplicated Influenza

Completed
NCT00610935Phase 3

Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza

Terminated
NCT02609399Phase 4

ED Influenza Therapeutic Pilot Study: Oseltamivir vs. Peramivir

Completed
NCT00297050Phase 1

Safety and Dose Study of Peramivir for Influenza Treatment

Completed
NCT02665351Phase 2

Peramivir Treatment Response in Adults Hospitalized for Influenza-associated Lower Respiratory Tract Infections

Completed
NCT00705406Phase 2

A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza

Completed
NCT00957996Phase 3

Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza

Completed
NCT01224795Phase 3

A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.

Terminated
NCT01063933Phase 1

Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Peramivir in Children With Influenza

Withdrawn

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11